A chalasia is an immune-mediated destruction of the esophageal myenteric plexus whose etiology is unknown. [1] [2] [3] [4] Esophageal denervation markedly impairs esophageal emptying and its perception. 5 Classic symptoms include dysphagia, regurgitation, chest pain, and, on occasion, heartburn. Traditionally, symptoms have been used for assessment of achalasia and the response to treatment. However, symptoms have been poor predictors of successful therapy in long-term follow-up. 6 The goal of achalasia therapy is to improve esophageal emptying. This has been difficult to quantify. The timed barium esophagogram (TBE) directly measures esophageal emptying. It is easily performed, inexpensive, quantitative, repeatable, and comfortable Objective: Success of achalasia therapy is difficult to determine because repeated physiologic study is impractical and symptoms are subjective. Timed barium esophagography directly measures esophageal emptying and is simple to perform. This study (1) evaluates the assessment of myotomy by timed barium esophagography and (2) compares it with premyotomy and postmyotomy symptoms.
for the patient. 7, 8 This study (1) evaluates TBE assessment of myotomy and (2) compares the TBE findings with symptoms.
Patients and methods
Patients. From March 1995 to April 1999, 52 patients underwent esophagomyotomy for achalasia. The diagnosis was based on esophageal manometric criteria (incomplete lower esophageal sphincter relaxation and aperistalsis). Preoperative evaluation included clinical symptom assessment and upper gastrointestinal endoscopy. A TBE was performed on 50 of these patients as a baseline study premyotomy and in 45 of the 52 patients approximately 8 weeks postmyotomy. Mean age was 48 ± 17 years; other patient characteristics are presented in Table I. TBE. While standing, the patient ingested a low-density barium sulfate suspension (45% weight in volume) (E-Z-PAQUE; E-Z-EM, Westbury, NY). Patients were instructed to drink up to 250 mL within 30 to 45 seconds. The maximum volume was the amount the patient could tolerate comfortably without regurgitation or aspiration. In 29 of 50 patients, the amount of barium ingested was a full 250 mL. With the patient in a slightly left posterior oblique position, three-onone spot films (35 × 35 cm) of the esophagus were taken 1, 2, and 5 minutes after the last swallow of barium (Fig 1, A) . In each patient, the same volume of barium was given for both the premyotomy and postmyotomy studies (Fig 1, B) . The barium ingestion distance from the distal esophagus to the top of the barium column (barium height) and the maximum diameter of the barium column (barium width) were calculated. The 1-, 2-, and 5-minute barium heights and widths, as well as changes from 1 to 5 minutes, were used for analysis of the degree of esophageal emptying and reduction in esophageal diameter.
Symptom evaluation. Premyotomy and postmyotomy symptom evaluations were performed and recorded in the medical record according to a structured, graded format. 8 We extracted the evaluation mode closest to the time of the TBE. Symptoms assessed were dysphagia, regurgitation, chest pain, and heartburn. The frequency of each symptom was graded on a scale from 0 to 5 (0 = none; 1 = rare, 1 per month or less; 2 = occasional, once a week, up to 3 to 4 times a month; 3 = frequent, 2 to 4 times a week; 4 = often, once a day; 5 = severe, several times a day).
Data analysis. Categorical data are summarized as frequencies and percentages. Continuous variables are summarized parametrically as mean and standard deviation or nonparametrically as box plots with median, 25th, and 75th percentiles (bottom and top of box), range, and individual points.
Initially, we attempted to model the time-related change in height, width, and the product of these to estimate the rate of esophageal emptying. However, the accommodation of the esophagus to barium precluded a consistent pattern. Therefore, each timed measurement and the difference between the 5-minute and 1-minute values were analyzed for correlates of both barium height and width by multiple linear regression. Version 6.12 of SAS for Unix was used in the analyses (SAS Institute, Inc, Cary, NC). Regression diagnostics used were those recommended by Neter and colleagues. 9 McNemar's test was used to determine whether symptom prevalence changed from the premyotomy to postmyotomy assessment.
The focus of the analysis of premyotomy TBE was its relation to premyotomy symptoms (presence and graded severity of dysphagia, regurgitation, chest pain, and heartburn). We also sought associations with patient demography (sex, age, weight), lower esophageal pressure and relaxation (millimeters of mercury), and previous therapies (botulinum toxin type A injections [Botox; Allergan, Inc, Irvine, Calif], pneumatic dilations, and lower esophagus operations).
The focus of the analysis of the postmyotomy TBE was (1) the relation to premyotomy values of height and width, (2) postmyotomy symptoms, and (3) preoperative symptoms, manometry, and therapies.
Results

Success of myotomy
Barium column height. In a person with normal esophageal function, the esophagus should be emptied of 250 mL of barium within 10 to 20 seconds and have no residual barium at 1 minute. In contrast, these patients with achalasia had a median premyotomy barium column height of 19, 17, and 15 cm at 1, 2, and 5 minutes after barium ingestion (Fig 2) . Postmyotomy, The relation of premyotomy and postmyotomy barium column heights at 1 minute for each patient is depicted in Fig 3. Regardless of the premyotomy height, some patients had complete emptying by 1 minute postmyotomy. Thus, correlation between the premyotomy and postmyotomy barium column heights
The Journal of Thoracic and Cardiovascular Surgery Volume 120, Number 5 Kostic et al 937 number of premyotomy pneumatic dilations, the lower the barium column height at 1 and 2 minutes (Appendix Tables I and II) . Patients with premyotomy pneumatic dilations had 1-minute barium column heights of 16 ± 8.0 cm compared with 21 ± 7.0 cm (P = .03) in patients without dilations. Barium column width. A person with normal esophageal function has a maximum esophageal width by barium esophagogram of 2 to 3 cm and has a collapsed esophagus at 1 minute. In contrast, these patients with achalasia had a median width of the barium column premyotomy of 5.2, 4.8, and 4.5 cm at 1, 2, and 5 minutes after barium ingestion (Fig 5) . Postmyotomy, the median width of the barium column was 3.5, 3.0, and 1.0 cm at 1, 2, and 5 minutes after barium ingestion (Fig 6 ; P < .001 at each time).
The relation of premyotomy and postmyotomy barium column width at 1 minute for each patient is depicted in Fig 7. In contrast to the barium column height, there was a strong correlation between premyotomy and postmyotomy barium column widths: the larger the premyotomy width, the larger the postmyotomy width (r = 0.55, P < .001, n = 42 at 1 minute; r = 0.62, P < .001, n = 41 at 2 minutes; and r = 0.61, P < .001, n = 42 at 5 minutes, Fig 8) .
Demography, esophageal manometry, and prior therapy correlated weakly with premyotomy and postmyotomy barium column widths (Appendix Tables III and IV) .
Symptom assessment. Postmyotomy, despite the observation that only 29% of the patients had complete esophageal emptying at 1 minute, 36% at 2 minutes, and 49% at 5 minutes, 95% experienced complete or near-complete relief of each symptom (grades 0-1) (Table II) and 90% experienced complete or near-complete relief of all symptoms. The patients experiencing at least frequent (grades 2-5) symptoms were different patients for each symptom. One patient each had only chest pain or heartburn. One patient had dysphagia and regurgitation. One additional patient had dysphagia, regurgitation, chest pain, and heartburn.
Symptoms and the TBE. Premyotomy symptoms correlated weakly (-0.10 < r < 0.10) with barium column height, except for the severity of regurgitation, which worsened in proportion to the height of the barThe Journal of Thoracic and Cardiovascular Surgery Volume 120, Number 5 Kostic et al 939 ium column (r = 0.45, P = .001 at 1 minute; r = 0.38, P = .006 at 2 minutes; and r = 0.40, P = .004 at 5 minutes, Fig 9) . Premyotomy symptoms correlated weakly (-0.26 < r < 0.10) with barium column width, except for chest pain, which was weakly and inversely correlated with width (r = -0.31, P = .03 at 1 minute; r = -0.34, P = .02 at 2 minutes, and r = -0.28, P = .04 at 5 minutes). Premyotomy dysphagia was more severe when little change in width occurred from 1 to 5 minutes (r = 0.26, P = .07). Symptoms postmyotomy, which were rare, correlated poorly with residual barium column height and width.
Discussion
By the time symptoms of achalasia develop, the esophageal myenteric plexus has been irreparably damaged, if not totally replaced by fibrous tissue. Therefore, no therapy can restore normal esophageal function. The goal of palliative treatment is to convert the esophagus into a passive conduit and improve esophageal emptying by gravity. Because peristalsis does not return, it is unreasonable to expect normal esophageal emptying even with a successful myotomy. Assessment of the results of therapy for achalasia has been confusing because many patients and physicians expect restoration of normal esophageal emptying.
Previously, the only measure of esophageal emptying has been radionuclide studies. These are expensive, not widely available, provide poor anatomic detail, and are difficult to perform repeatedly. All other measurements indirectly assess esophageal emptying. These include manometry, simple barium esophagography, endoscopy, and imaging such as computed tomographic scanning.
The TBE is a simple test that directly measures liquid esophageal emptying. It is easy to do, requiring no special equipment or expertise. Therefore, TBE is repeatable and can be performed at institutions other than the one at which treatment was undertaken. It is also inexpensive, quantitative, and comfortable for the patient. These factors make it an ideal, practical test for serial assessments of esophageal emptying. Successful treatment by myotomy is reflected in improved emptying of the esophagus, resulting in both a decreased height and width of the esophagus.
The less the esophagus was dilated premyotomy, the greater the improvement in esophageal emptying. Both the height and width of the barium column postmyotomy were directly related to the premyotomy width. The neural destruction in achalasia results in an abnormal relaxation of the lower esophageal sphincter and aperistalsis of the esophageal body. Therapy is directed only at the lower esophageal sphincter and assumes that relief of obstruction will result in restoration of normal esophageal width. However, dilation of the esophagus also may reflect or result in decompensation of the esophageal body that may not be reversed by therapy. We interpret the correlation of TBE height and width 
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postmyotomy as reflecting the degree of irreversible decompensation, whereas the lack of correlation premyotomy reflects the dominance of lower esophageal obstruction. So that esophageal emptying can be facilitated and the denervated esophagus maximally palliated, early and effective treatment should be undertaken to prevent dilation of the esophagus. Because of its simplicity, symptom relief traditionally is used to assess the outcome of achalasia therapy. However, disparity between symptomatic response and objective improvement in achalasia has been noted. [10] [11] [12] [13] [14] There are three probable explanations for this dissociation. First, swallowing is so difficult for patients with achalasia that any improvement is often exaggerated. Second, eating is such a great part of our social lives that any improvement is greatly appreciated. 15 Third, denervation of the esophagus alters perception of swallowing. 5 Consequently, it is difficult to determine the success of therapy by symptom evaluation alone.
The association of premyotomy symptoms to TBE has interesting physiologic and pathologic correlations. In the process of esophageal denervation with incomplete lower esophageal sphincter relaxation, the height of the barium column increases because of incomplete emptying. As the obstruction persists, the esophagus decompensates over time by dilating, as in the failing myocardium. Physiologically, regurgitation is likely to be the principal symptom if a large volume of barium is close to the pharynx, as measured by barium column height. Similarly, the symptom of dysphagia is worse if there is less emptying of the esophagus, as reflected by a lack of change in width from 1 to 5 minutes. Early in the destructive process, when the esophagus is not very dilated, the partially denervated esophagus is more likely to undergo lumen-occluding spasm (vigorous achalasia), causing the patient to have chest pain. Patients with significant chest pain may be the best candidates for aggressive surgical management since they are likely to have a less dilated esophagus.
Symptoms postmyotomy are unrelated to esophageal emptying and are poor measures of success of therapy. Therefore, TBE should be included in the preoperative evaluation and postoperative follow-up of all patients undergoing therapy for achalasia. It defines the physiologic success of surgery, prevents unnecessary operation when symptoms persist or recur, and prompts further study and possible therapy in the asymptomatic patient with unimproved esophageal emptying. residual symptoms are present in a patient with an aperistaltic esophagus. Given this apparent lack of correlation between residual symptoms and the improvement in esophageal emptying by TBE, the authors state that the TBE is thus useful in establishing that emptying has improved in patients with persisting symptoms and thus in preventing subsequent unnecessary surgery.
The essential question, though, is this: What is the cause of the persisting symptoms and which study best delineates that cause? About a year ago, Alonso and associates reported that manometric examination accurately records whether a satisfactory myotomy has been performed, and I concur with that.
Patients with residual symptoms after myotomy fall into several possible categories. First, they have had an adequate myotomy, but symptoms persist because of the denervation. Second, they have had an inadequate myotomy despite an improvement in emptying because the esophagus is aperistaltic. Alonso and associates, in their article, did define the levels of postoperative pressure manometrically that would result in persistent symptoms. The third possibility is that the patient now has reflux and all the problems of reflux. In all of these possibilities, the esophagogram would show improvement, but manometry might differentiate these possibilities. Thus, I believe that the esophagogram is a useful adjunct in the assessment of these patients, but I question whether it can replace manometry in accurate assessment of ongoing pathophysiology. I have 2 questions: First, did you perform manometry and pH studies postoperatively in the patients with residual symptoms so that you could then compare these results with the esophagogram? Second, particularly as I know you use esophagography after balloon dilatation, do you have any longitudinal data of esophagography to indicate whether it subsequently changes when recurrent symptoms develop after an initial improvement?
Dr Steve R. DeMeester (Los Angeles, Calif). Did you identify a cutoff point at which the esophagus was so dilated that you could predict with reliability that it was not going to empty well postoperatively? Along those same lines, did you try a myotomy on patients whose esophagus had a sigmoid shape, and who generally are not considered to be good candidates for myotomy? What type of fundoplication did you use, and was there a difference between a Toupet or a Dor procedure? Last, did you compare surgical myotomy and balloon dilatation in terms of timed emptying?
Dr Antoon E. M. R. Lerut (Leuven, Belgium). The timing of this study, 8 weeks after the operation, seems too early since postoperative edema and all the related changes have not resolved. Did you perform some studies later, at 4 or 6 months, for instance, and was there any difference compared with the results at 8 weeks?
Dr DeCamp. I would like to thank the discussants for their insightful questions.
To address Dr Todd, 95% of patients had effective relief of symptoms, so it was a vast minority of patients who had residual symptoms. Those patients whose symptoms were severe enough to make them consider having another intervention, namely, either balloon dilatation, which we have done on a rare occasion, or a reoperation, underwent extensive re-evaluation, including a pH study and repeat manometry. These studies were designed to discriminate between reflux disease and a stricture (of which we think we have 2 fairly well-documented cases) or an incomplete myotomy.
The issue of residual lower esophageal sphincter pressure is a bit of a moving target. What I did not discuss is the fundoplication associated with myotomy. Our experience is certainly an evolving one. Initially the patients rather routinely had a Toupet procedure. We did not use Dor procedures, preferring the more minimal dissection of the hiatal mechanism and not using any fundoplication in our most recent series. Forty-seven of the 52 patients whom we discussed had their procedure performed laparoscopically. So, to address Dr Lerut, I think 8 weeks is probably sufficient for resolution of postoperative edema from a laparoscopic procedure.
Regarding the question by Dr Todd, in terms of longterm follow-up, it is our practice to recommend careful follow-up of those patients who have incomplete emptying, those whom we think are at risk for the development of sigmoid deformity. This paper is considering just a surgical series. When we look at all patients, we are evaluating both the medical and surgical management. We think this tool is also useful for patients in the balloon dilatation group. The patient whose condition is symptomatically improved by balloon dilatation but who by esophagogram has residual dilatation should be observed carefully and closely, and surgical intervention should be recommended before a sigmoid deformity develops.
Dr DeMeester asked whether we have a cutoff above which we would predict poor emptying. At 6 cm or less, we expect good outcomes symptomatically. On esophagogram, above 6 cm we continue to expect good symptomatic relief but also expect residual barium column height and width. We do offer almost all patients, other than those with the most grotesque sigmoid deformities, an attempt at a reparative procedure because the symptomatic improvement is so great and because a certain subset of these patients will be elderly and not particularly good candidates for esophageal resection. In addressing fundoplication, I observed that our experience is evolving. We believe that the Toupet procedure is a slightly better approach, which allows us to tack our myotomy open, whereas the Dor procedure tends to cover up what we have done.
